Send me a link:

*Text messaging rates may apply.

 Dow Up0.47% Nasdaq Up0.63%

Celgene Corporation (CELG)

-NasdaqGS
87.52 1.80(2.10%) Jul 9, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 6,493,900   5,506,700   4,842,100  
Cost of Revenue340,400  299,100  425,900  
Gross Profit 6,153,500   5,207,600   4,416,200  
Operating Expenses
Research Development2,226,200  1,724,200  1,600,300  
Selling General and Administrative1,684,500  1,373,500  1,226,300  
Non Recurring171,100  169,000  (142,300)
Others262,800  194,500  289,200  
Total Operating Expenses4,344,600  3,461,200  2,973,500  
Operating Income or Loss 1,808,900   1,746,400   1,442,700  
Income from Continuing Operations
Total Other Income/Expenses Net(51,900)(1,700)19,500  
Earnings Before Interest And Taxes1,757,000  1,744,700  1,462,200  
Interest Expense91,600  63,200  42,700  
Income Before Tax1,665,400  1,681,500  1,419,500  
Income Tax Expense215,500  225,300  102,100  
Minority Interest -   -  700  
Net Income From Continuing Ops1,449,900  1,456,200  1,318,100  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 1,449,900   1,456,200   1,318,100  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 1,449,900   1,456,200   1,318,100  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.